Trial Details

COMPLETED
Basic Information
Clinical ID c705
Identifier NCT04071405
Trial Title Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions OTHER: Non-intervention
Participant Information
Sponsor Pfizer
City Seoul
Country/Region Korea, Republic of
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2020-05-12
Primary Completion Date 2022-09-26
Completion Date 2022-09-26